FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Buy Opinion On Shares Of The Pnc Financial Services Group, Inc.

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

After reviewing Q1 2026 earnings, we increase our 12-month target price by $10 to $300, 14.3x our 2027 EPS estimate, a premium to the peer average of 10.0x given PNC's more stable operating model. With the FirstBank acquisition off to a strong start, we raise our 2026 EPS estimate by $0.97 to $18.96 and increase 2027's by $1.45 to $20.92. PNC is performing well, with balance sheet growth exceeding its competitors and strong organic growth prospects driven by branch expansion into high-growth states. The company's solid first-quarter performance enabled it to raise guidance for both loan growth and net interest income while holding expense guidance steady, a positive signal for future profitability. Regarding concerns about Non-Depository Financial Institution (NDFI) loan exposure, PNC appears to be well protected. Roughly 90% of these loans carry investment-grade ratings and management considers them among the bank's safest assets. Shares yield a healthy 3.0%

相關文章

Asia

Euroz Hartleys表示,Emerald Resources的勘探成功支撐了其多元資產成長。

週二,Euroz Hartleys在一份報告中指出,Emerald Resources(ASX:EMR)近期在西澳大利亞的Dingo Range金礦項目及其他地區的勘探成功,鞏固了該公司多元化資產增長和產能擴張的戰略。 Euroz Hartleys表示,Dingo Range的鑽探證實了強烈的礦化作用,露天礦資源的加密鑽探結果也印證了這一點。此外,Freeman's Find礦床持續延伸,並取得了顯著的礦化截獲。 同時,柬埔寨Memot金礦計畫的密集反循環加密鑽探預計將有助於儲量轉化,同時評估潛在的礦石損失和稀釋情況,該計畫的資源量仍有成長空間。 這家股票研究公司表示,Okvau金礦的鑽探持續顯示出地下增產潛力,這支持延長礦山壽命,並有望在目前每年約10萬至12萬盎司的產量基礎上實現未來的增產。鑑於該公司目前已產生大量現金流,這一點至關重要。 Euroz Hartleys維持對該股的買入評級,目標價為8.10澳元。 Emerald Resources的股價在周三的交易中下跌了2%。

$ASX:EMR
Asia

阿旃陀製藥印度派坦工廠檢查後,收到美國FDA五項觀察。

根據提交給印度證券交易所的文件顯示,阿旃陀製藥(Ajanta Pharma,NSE:AJANTPHARM,BOM:532331)位於印度馬哈拉施特拉邦派坦的生產工廠已完成美國食品藥物管理局(FDA)的檢查,並收到FDA提出的五項觀察意見。 FDA於4月13日至21日對該工廠進行了檢查,並最終出具了包含五項觀察意見的483表格。 該公司表示將在規定的時間內對FDA作出回應。 該公司股價在最近的交易中下跌了近1%。

$BOM:532331$NSE:AJANTPHARM
Asia

Pateo Connect與Horizon Robotics Technology合作開發人工智慧驅動車輛系統

根據週三在香港交易所發布的公告顯示,上海帕特奧互聯科技股份有限公司(港交所代碼:2889)與北京地平線機器人技術研發有限公司簽署合作協議。 雙方將攜手開發智慧座艙和自動駕駛的整合解決方案,並推進機器人和車輛智慧領域的應用。 兩家公司也計劃透過共享客戶資源和開拓海外汽車市場,共同拓展全球業務。

$HKG:2889